UniProt ID | ARC1B_HUMAN | |
---|---|---|
UniProt AC | O15143 | |
Protein Name | Actin-related protein 2/3 complex subunit 1B | |
Gene Name | ARPC1B {ECO:0000312|HGNC:HGNC:704} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 372 | |
Subcellular Localization | Cytoplasm, cytoskeleton . | |
Protein Description | Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.. | |
Protein Sequence | MAYHSFLVEPISCHAWNKDRTQIAICPNNHEVHIYEKSGAKWTKVHELKEHNGQVTGIDWAPESNRIVTCGTDRNAYVWTLKGRTWKPTLVILRINRAARCVRWAPNENKFAVGSGSRVISICYFEQENDWWVCKHIKKPIRSTVLSLDWHPNNVLLAAGSCDFKCRIFSAYIKEVEERPAPTPWGSKMPFGELMFESSSSCGWVHGVCFSASGSRVAWVSHDSTVCLADADKKMAVATLASETLPLLALTFITDNSLVAAGHDCFPVLFTYDAAAGMLSFGGRLDVPKQSSQRGLTARERFQNLDKKASSEGGTAAGAGLDSLHKNSVSQISVLSGGKAKCSQFCTTGMDGGMSIWDVKSLESALKDLKIK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAYHSFLVE ------CCCEEEEEC | 15.67 | - | |
18 | Acetylation | ISCHAWNKDRTQIAI CCEEEECCCCCEEEE | 37.57 | 23749302 | |
18 | Ubiquitination | ISCHAWNKDRTQIAI CCEEEECCCCCEEEE | 37.57 | - | |
21 | Phosphorylation | HAWNKDRTQIAICPN EEECCCCCEEEECCC | 34.17 | 14749719 | |
35 | Phosphorylation | NNHEVHIYEKSGAKW CCCEEEEEECCCCCE | 11.48 | 28152594 | |
37 | Acetylation | HEVHIYEKSGAKWTK CEEEEEECCCCCEEE | 36.90 | 23749302 | |
37 | Ubiquitination | HEVHIYEKSGAKWTK CEEEEEECCCCCEEE | 36.90 | - | |
41 | Acetylation | IYEKSGAKWTKVHEL EEECCCCCEEEEEEH | 59.94 | 23749302 | |
44 | Acetylation | KSGAKWTKVHELKEH CCCCCEEEEEEHHHH | 40.24 | 19608861 | |
44 | Ubiquitination | KSGAKWTKVHELKEH CCCCCEEEEEEHHHH | 40.24 | 19608861 | |
49 | Ubiquitination | WTKVHELKEHNGQVT EEEEEEHHHHCCEEE | 54.68 | - | |
49 | Malonylation | WTKVHELKEHNGQVT EEEEEEHHHHCCEEE | 54.68 | 32601280 | |
77 | Phosphorylation | CGTDRNAYVWTLKGR EECCCCEEEEEECCC | 10.48 | - | |
80 | Phosphorylation | DRNAYVWTLKGRTWK CCCEEEEEECCCCCC | 14.46 | 22985185 | |
82 | Acetylation | NAYVWTLKGRTWKPT CEEEEEECCCCCCCE | 38.68 | 23954790 | |
82 | Ubiquitination | NAYVWTLKGRTWKPT CEEEEEECCCCCCCE | 38.68 | 21906983 | |
85 | Phosphorylation | VWTLKGRTWKPTLVI EEEECCCCCCCEEEE | 46.65 | 20068231 | |
87 | Ubiquitination | TLKGRTWKPTLVILR EECCCCCCCEEEEEE | 27.75 | - | |
89 | Phosphorylation | KGRTWKPTLVILRIN CCCCCCCEEEEEEEC | 29.90 | 20068231 | |
110 | Ubiquitination | RWAPNENKFAVGSGS EECCCCCCEECCCCC | 28.64 | 21890473 | |
110 | Acetylation | RWAPNENKFAVGSGS EECCCCCCEECCCCC | 28.64 | 26051181 | |
138 | Ubiquitination | WWVCKHIKKPIRSTV EEEEEECCCCCEEEE | 52.82 | - | |
170 | Phosphorylation | DFKCRIFSAYIKEVE CCEEEEEEEEEHHHH | 20.14 | 20068231 | |
172 | Phosphorylation | KCRIFSAYIKEVEER EEEEEEEEEHHHHCC | 16.01 | 28152594 | |
174 | Acetylation | RIFSAYIKEVEERPA EEEEEEEHHHHCCCC | 42.93 | 23954790 | |
174 | Ubiquitination | RIFSAYIKEVEERPA EEEEEEEHHHHCCCC | 42.93 | - | |
183 | Phosphorylation | VEERPAPTPWGSKMP HHCCCCCCCCCCCCC | 33.51 | - | |
187 | Phosphorylation | PAPTPWGSKMPFGEL CCCCCCCCCCCCCCE | 23.16 | 27251275 | |
233 | Acetylation | VCLADADKKMAVATL EEEECCCHHHHHHHH | 46.28 | 25953088 | |
289 | Ubiquitination | GGRLDVPKQSSQRGL CCCCCCCCCCHHCCC | 63.76 | - | |
291 | Phosphorylation | RLDVPKQSSQRGLTA CCCCCCCCHHCCCCH | 34.27 | 22985185 | |
292 | Phosphorylation | LDVPKQSSQRGLTAR CCCCCCCHHCCCCHH | 22.77 | 24719451 | |
297 | Phosphorylation | QSSQRGLTARERFQN CCHHCCCCHHHHHHC | 26.88 | 22817900 | |
307 | 2-Hydroxyisobutyrylation | ERFQNLDKKASSEGG HHHHCHHHHHHCCCC | 54.10 | - | |
307 | Ubiquitination | ERFQNLDKKASSEGG HHHHCHHHHHHCCCC | 54.10 | - | |
307 | Acetylation | ERFQNLDKKASSEGG HHHHCHHHHHHCCCC | 54.10 | 27452117 | |
308 | Malonylation | RFQNLDKKASSEGGT HHHCHHHHHHCCCCC | 53.84 | 32601280 | |
308 | Ubiquitination | RFQNLDKKASSEGGT HHHCHHHHHHCCCCC | 53.84 | - | |
310 | Phosphorylation | QNLDKKASSEGGTAA HCHHHHHHCCCCCCC | 37.49 | 29255136 | |
311 | Phosphorylation | NLDKKASSEGGTAAG CHHHHHHCCCCCCCC | 45.16 | 23401153 | |
315 | Phosphorylation | KASSEGGTAAGAGLD HHHCCCCCCCCCCCH | 24.96 | 21712546 | |
323 | Phosphorylation | AAGAGLDSLHKNSVS CCCCCCHHHHCCCCC | 37.10 | 23403867 | |
326 | Ubiquitination | AGLDSLHKNSVSQIS CCCHHHHCCCCCEEE | 57.10 | - | |
326 | Acetylation | AGLDSLHKNSVSQIS CCCHHHHCCCCCEEE | 57.10 | 25953088 | |
326 | Methylation | AGLDSLHKNSVSQIS CCCHHHHCCCCCEEE | 57.10 | - | |
326 | Malonylation | AGLDSLHKNSVSQIS CCCHHHHCCCCCEEE | 57.10 | 26320211 | |
328 | Phosphorylation | LDSLHKNSVSQISVL CHHHHCCCCCEEEEE | 28.13 | 20068231 | |
330 | Phosphorylation | SLHKNSVSQISVLSG HHHCCCCCEEEEEEC | 22.93 | 20068231 | |
333 | Phosphorylation | KNSVSQISVLSGGKA CCCCCEEEEEECCEE | 14.90 | 28857561 | |
336 | Phosphorylation | VSQISVLSGGKAKCS CCEEEEEECCEEEHH | 43.26 | 25159151 | |
339 | Ubiquitination | ISVLSGGKAKCSQFC EEEEECCEEEHHHCC | 48.47 | - | |
341 | Ubiquitination | VLSGGKAKCSQFCTT EEECCEEEHHHCCCC | 37.59 | - | |
355 | Phosphorylation | TGMDGGMSIWDVKSL CCCCCCCCHHHHHHH | 24.65 | 22817900 | |
360 | Ubiquitination | GMSIWDVKSLESALK CCCHHHHHHHHHHHH | 47.02 | - | |
361 | Phosphorylation | MSIWDVKSLESALKD CCHHHHHHHHHHHHH | 36.90 | 20873877 | |
364 | Phosphorylation | WDVKSLESALKDLKI HHHHHHHHHHHHCCC | 44.16 | 23312004 | |
367 | 2-Hydroxyisobutyrylation | KSLESALKDLKIK-- HHHHHHHHHCCCC-- | 61.81 | - | |
367 | Malonylation | KSLESALKDLKIK-- HHHHHHHHHCCCC-- | 61.81 | 26320211 | |
367 | Ubiquitination | KSLESALKDLKIK-- HHHHHHHHHCCCC-- | 61.81 | - | |
367 | Acetylation | KSLESALKDLKIK-- HHHHHHHHHCCCC-- | 61.81 | 25953088 | |
370 | Ubiquitination | ESALKDLKIK----- HHHHHHCCCC----- | 59.59 | - | |
372 | Ubiquitination | ALKDLKIK------- HHHHCCCC------- | 53.34 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARC1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARC1B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-44 AND LYS-82, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY. |